Budesonide/formoterol pressurized metered-dose inhaler

Drugs

Volumn 68, Issue 13, 2008, Pages 1855-1864

  Lyseng Williamson, Katherine A ^a,b   Simpson, Dene ^a,b  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

^b WOLTERS KLUWER HEALTH   (United States)

Author keywords

Adis Drug Profiles; Asthma; Budesonide formoterol, general; Metered dose inhalers

Indexed keywords

BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; FORMOTEROL; SALBUTAMOL; TERBUTALINE;

AREA UNDER THE CURVE; ASTHMA; BACKACHE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEADACHE; HEART VENTRICLE TACHYCARDIA; HUMAN; INFLUENZA; MAXIMUM PLASMA CONCENTRATION; METERED DOSE INHALER; MONOTHERAPY; NOSE CONGESTION; OUTCOME ASSESSMENT; PRESSURIZED METERED DOSE INHALER; QUALITY OF LIFE; REVIEW; RHINOPHARYNGITIS; SIDE EFFECT; SINUSITIS; SORE THROAT; STOMACH DISCOMFORT; SUPRAVENTRICULAR TACHYCARDIA; SYMPTOM; T WAVE INVERSION; THRUSH; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; BUDESONIDE; DRUG COMBINATIONS; ETHANOLAMINES; HUMANS; METERED DOSE INHALERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 50249131864     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200868130-00005     Document Type: Review

References (23)

1. Guidelines for the diagnosis and management of asthma: summary report 2007. Bethesda (MD): National Heart, Lung, and Blood Institute; 2007 Oct
2. 2-agonists and corticosteroids. Eur Respir J 2002; 19 (1): 182-91
3. Symbicort® (budesonide and formoterol fumarate dihydrate) inhalation aerosol: US prescribing information. Wilmington (DE): AstraZeneca LP, 2007 Oct
4. Goldsmith DR, Keating GM. Budesonide/formoterol: a review of its use in asthma. Drugs 2004; 64 (14): 1597-618
5. McCormack PL, Lyseng-Williamson KA. Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma. Drugs 2007; 67 (16): 2407-31
6. Brogden RN, McTavish D. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. Drugs 1992; 44 (3): 375-407
7. Faulds D, Hollingshead LM, Goa KL. Formoterol: a review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. Drugs 1991 Jul; 42 (1): 115-37
8. Remington TL, DiGiovine B. Long-acting β-agonists: antiflammatory properties and synergy with corticosteroids in asthma. Curr Opin Pulm Med 2005 Jan; 11 (1): 74-8
9. Capraz F, Kunter E, Ilvan A, et al. The effect of inhaled budesonide and formoterol on bronchial remodeling in young asthmatics [abstract no. P1243]. Eur Respir J Suppl 2006 Sep; 28 Suppl. 50: 208s
10. Maneechotesuwan K, Essilfie-Quaye S, Meah S, et al. Formoterol attenuates neutrophilic airway inflammation in asthma. Chest 2005 Oct; 128 (4): 1936-42
11. Hampel FC, Martin P, Mezzanotte S. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. J Asthma 2008 May; 45 (4): 265-72
12. Kaiser HB, Miller CJ, O'Dowd L. Measured onset of bronchodilation with budesonide and formoterol administered via one pressurized metered-dose inhaler (pMDI) in patients with asthma previously receiving inhaled corticosteroids [abstract no. 974]. J Allergy Clin Immunol 2007 Jan; 119 (1 Suppl.): S249
13. Adner M, Cardell L-O, Naya MI, et al. Budesonide prevents cytokine-induced decrease of the relaxant response to formoterol and terbutaline but not salmeterol in mouse trachea [abstract]. Am J Respir Crit Care Med 2007; 175 Suppl. 1: A463
14. Corren J, Korenblat PE, Miller CJ, et al. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Clin Ther 2007 May; 29 (5): 823-43
15. Noonan M, Rosenwasser LJ, Martin P, et al. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial [published erratum appears in Drugs 2007; 67 (5): 759]. Drugs 2006; 66 (17): 2235-54
16. Peters SP, Prenner BM, Mezzanotte WS, et al. Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. Allergy Asthma Proc. Epub 2008 Aug 8
17. Ankerst J, Lotvall J, Tronde A, et al. Pharmacokinetics and systemic bioavailability of budesonide (BUD) and formoterol (FM) administered via one pressurized metered-dose inhaler (pMDI) in adults and children with asthma [abstract]. Am J Respir Crit Care Med 2007; 175 Suppl. 1: A192
18. Ankerst J, Lotvall J, Tronde A, et al. Systemic bioavailability of budesonide (BUD) and formoterol (FM) administered via one pressurized metered-dose inhaler (pMDI) in asthma patients and healthy subjects [abstract]. Am J Respir Crit Care Med 2007; 175 Suppl. 1: A192
19. Morice AH, Peterson S, Beckman O, et al. Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. Int J Clin Pract 2007 Nov; 61 (11): 1874-83
20. Murphy K, Nelson H, Parasuraman B, et al. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. Curr Med Res Opin 2008; 24 (3): 879-94
21. Chervinsky P, Baker J, Bensch G, et al. Improvement in health-related quality of life (HRQL) after use of budesonide (BUD) and formoterol (FM) in one pressurized metered-dose inhaler (pMDI) in adults with moderate to severe asthma [abstract]. Am J Respir Crit Care Med 2007; 175 Suppl. 1: A781
22. Baker J, Martin P, Parasuraman B. Patient satisfaction with budesonide and formoterol in one pressurized metered-dose inhaler in patients with asthma [abstract]. Chest 2007 Oct; 132 (4 Suppl.): 509S
23. Morice AH, Hochmuth L, Ekelund J, et al. Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler® in adolescents and adults with asthma. Pulm Pharmacol Ther 2008 Feb; 21 (1): 32-9